Current report 42/2021 – Registration of D-series shares with the KDPW

Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information

Content of the report:                                                                                                                                

The Management Board of Celon Pharma S.A. (the “Company”) hereby announces that it was informed of the publication of an announcement by Krajowy Depozyt Papierów Wartościowych S.A. on the registration in the securities depository of 6,000,000 of the Company's ordinary D-series bearer shares under ISIN PLCLNPH00015 code on September 22, 2021.

Therefore, the condition for the introduction of the aforementioned shares to trading on the primary market of the Warsaw Stock Exchange on September 22, 2021 has been meet.